About
- About Avecho
- Board & Leadership
TPM^® Technology
Portfolio
Invest
- Investor Centre
- Media Centre
Contact

Hit enter to search or ESC to close

Phosphagenics Signs Japanese License Option Agreement and R&D Alliance

April 29, 2016

click here to read more

Post navigation

2015 Annual Report

Phosphagenics Signs Japanese License Option Agreement for TPM Oxycodone Patch

Related Posts

Ethics Approval to Commence Topical TPM®/Oxycodone Patch Trial

December 8, 2014

Avecho’s Phase III Clinical Trial for Insomnia Commences

March 26, 2024March 26, 2024

Investor Presentation April 2018

April 17, 2018

Recent Posts

US & EU Patent Allowances for CBD Soft-Gel Formulation
December 3, 2025
Research report | RaaS Watchlist: Waking the Sleeping Giant
August 26, 2025
Media | Avecho featured on 9 News
June 23, 2025

Categories

Analyst Coverage
Company Announcement
Company Report
Investor Webinar
Media Coverage
Newsletter
Press Release
Uncategorised

About us

We see a future where more patients can get even more from their treatments through innovative delivery technologies.

Stay Posted

Stay informed about our latest news and developments.

Leave this field empty if you're human:

About Avecho

TPM^® Technology

Portfolio

Investor Centre
- Investor Centre
- Media Centre

© Copyright 2019 Avecho Biotechnology Ltd.